Patent 11123383 was granted and assigned to MyBiotics Pharma on September, 2021 by the United States Patent and Trademark Office.
The present invention provides a composition comprising a co-culture of at least two distinct bacterial families, having differing growth and/or proliferative conditions. In some embodiments, the composition comprises a plurality of bacterial genera with high similarity to microbial flora.